The vitamin market continues to display a mix of stability and cautious activity across key segments as we approach the fourth quarter. While price declines have slowed and contracts are steadily being secured for upcoming periods, subdued transaction volumes highlight an underlying atmosphere of uncertainty and watchfulness. The following summary outlines the latest developments and pricing dynamics.
In partnership with Feed Additive Prices
Vitamin E 50%
While most suppliers seem reluctant to adjust to the recent drop in prices, with many either halting their offers or maintaining prices above market levels, overall availability along the entire supply chain appears to remain strong, contributing to a landscape of stable to weak pricing. However, transaction activity has been limited, indicating a notably quiet market environment, and as we move into the fourth quarter, a portion of contracts has already been secured.
Vitamin A 1000
The price landscape has recently shown signs of stabilisation across most regions, remaining at a notably low level. Some buyers are beginning to secure contracts for their remaining needs in the fourth quarter and even into the first quarter, while others are exercising caution, uncertain if prices might drop further in the upcoming months. Manufacturers appear less enthusiastic about selling at these price points, primarily leaving traders, resellers, and distributors to offer the most competitive prices in the market.
Vitamin D3 500
The ongoing market dynamics remain unchanged, with certain manufacturers persistently pricing their materials at elevated levels while others significantly undercut those prices, resulting in a substantial price disparity. Despite this, the majority of transactions are occurring at the lower end of the pricing spectrum, which, while still higher than historical market values, reflects a notable shift in the overall landscape. Additionally, a considerable portion of contracts for the fourth quarter has already been secured.
D-Calpan
Several suppliers continue to offer these already low prices to maintain their market share, although the pace of decline has slowed. Buyers are now taking advantage of the low prices by securing some volume to mitigate potential risks if the market shifts. Currently, the market feels relatively calm, with prices remaining stable and slightly weak at these low levels. A significant portion of contracts for Q4 has already been secured.
Vitamin B3
As most suppliers have shifted away from price reductions to boost volume, many have either ceased offering or maintained specific price levels. This resulted in a relatively stable market characterised by exceptionally low prices. While a few buyers have taken this opportunity to evaluate their risks and secure Q4 and some Q1 volumes at these low price points, albeit with a level of caution still prevailing among certain buyers.
